Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
International Journal of Medicinal Mushrooms
Factor de Impacto: 1.423 Factor de Impacto de 5 años: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN En Línea: 1940-4344

Volumes:
Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v7.i12.200
pages 213-220

Combination Therapy of Transplanted Meth-A Fibrosarcoma in BALB/c Mice with Protein-Bound Polysaccharide EA6 Isolated from Enokitake Mushroom Flammulina velutipes (W.Curt.:Fr.)Singer and Surgical Excision

Hirofumi Maruyama
Japanese Association for Integrative Medicine, Kandakonya-cho, Tokyo, Japan
Tetsuro Ikekawa
Japanese Association of Integrative Medicine (JAIM). Association for Popularization of Integrative Medicine and Treatments (NPO, Japan), Sanshin Building, 3F, 2-15-14 Uchikanda, Chiyoda-ku, Tokyo 101-0047,Japan

SINOPSIS

The present study demonstrates the antitumor effect of treatment combining protein-bound polysaccharide EA6 isolated from culinary—medicinal mushroom Flammulina velutipes with surgical excision (SE) in mice using Meth-A fibrosarcoma. Oral administration of EA6 alone exhibited no inhibitory effect on the growth of intradermally inoculated Meth-A tumor cells, although it was effective for increasing the lifespan in mice bearing Lewis lung carcinoma or B-16 melanoma. In Meth-A fibrosarcoma, EA6, when administered orally, displayed a marked antitumor effect against the same tumor rechallenged after SE. When oral administration of EA6 (10 mg/kg/day) was begun on post-excision day 1, the growth of the secondary tumor inoculated on post excision day 7 was significantly inhibited. When mice showed this inhibitory effect for the second solid tumor challenged, immune activity of the mice was tested. EA6 was found to enhance both humoral (i.e., antibody response to sheep red blood cells) and cell-mediated (i.e., anti-Meth-A delayed-type hypersensitivity response) immunity. In tumor neutralization tests, the spleen cells from mice treated with both EA6 and SE markedly inhibited the growth of admixed Meth-A tumor cells. The antitumor immunity of the spleen cells was eliminated by treatment with anti-CD4 monoclonal antibody plus complement, but not with anti-CD8 monoclonal antibody plus complement. These results suggest that EA6 augments the antitumor immunity in combination with SE, and the effect is mediated by CD4-positive T cells.


Articles with similar content:

Immunomodulation and Antitumor Activity of a Mushroom Product, Proflamin, Isolated from Flammulina velutipes (W. Curt.: Fr.) Singer (Agaricomycetideae)
International Journal of Medicinal Mushrooms, Vol.9, 2007, issue 2
Tetsuro Ikekawa, Hirofumi Maruyama
Immunotherapy of Colon Cancer Using Chimeric mAb 31.1
Critical Reviews™ in Immunology, Vol.18, 1998, issue 1-2
Tommy Wang, Myron Arlen, Al Tsang
Inhibitory Effects of Extracts from Agaricus brasiliensis S. Wasser et al. (Agaricomycetideae) on Immediate Type Allergy Induced Compound 48/80 in ICR Mice
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Sachiko Kawakami, Yasushi Chida, Masashi Mizuno
Th1-Oriented Immunomodulating Activity of Gel-Forming Fungal (1®3)-Beta-Glucans
International Journal of Medicinal Mushrooms, Vol.4, 2002, issue 2
Toshiro Yadomae, Naohito Ohno, Takafumi Jinushi
Inhibitory Effects of Edible Higher Basidiomycetes Mushroom Extracts on Mouse Type IV Allergy
International Journal of Medicinal Mushrooms, Vol.4, 2002, issue 1
Tetsuro Ikekawa, Mitsuaki Sano, Tsunetomo Matsuzawa, Kyoji Yoshino